Login / Signup
Xiaoyan Qiang
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Small Molecule
Study Protocol
Lymph Node Metastasis
Protein Kinase
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Peng Peng
,
Xiaoyan Qiang
,
Guoyu Li
,
Lin Li
,
Shumao Ni
,
Qi Yu
,
Laura Sourd
,
Elisabetta Marangoni
,
Chao Hu
,
Dong Wang
,
Di Wu
,
Frank Wu
Tinengotinib (TT-00420), a Novel Spectrum-Selective Small Molecule Kinase Inhibitor, Is Highly Active Against Triple Negative Breast Cancer.
Molecular cancer therapeutics
(2022)